LetterLetter
Chilblains After SARS-CoV-2 Vaccination: Coincidence or Real Association?
Anastasios Karamanakos, Gerasimos Evangelatos, Maria Pappa, Kalliopi Fragiadaki, Antonis Fanouriakis and George E. Fragoulis
The Journal of Rheumatology August 2022, jrheum.220487; DOI: https://doi.org/10.3899/jrheum.220487
Anastasios Karamanakos
Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. G.E. Fragoulis, Joint Academic Rheumatology Program, First Department of Propedeutic Internal Medicine, Laiko Hospital, School of Medicine, National and Kapodistrian University of Athens, Agiou Thoma 17 Goudi, 11527, Athens, Greece. Email: geofragoul@yahoo.gr.
Gerasimos Evangelatos
Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. G.E. Fragoulis, Joint Academic Rheumatology Program, First Department of Propedeutic Internal Medicine, Laiko Hospital, School of Medicine, National and Kapodistrian University of Athens, Agiou Thoma 17 Goudi, 11527, Athens, Greece. Email: geofragoul@yahoo.gr.
Maria Pappa
Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. G.E. Fragoulis, Joint Academic Rheumatology Program, First Department of Propedeutic Internal Medicine, Laiko Hospital, School of Medicine, National and Kapodistrian University of Athens, Agiou Thoma 17 Goudi, 11527, Athens, Greece. Email: geofragoul@yahoo.gr.
Kalliopi Fragiadaki
Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. G.E. Fragoulis, Joint Academic Rheumatology Program, First Department of Propedeutic Internal Medicine, Laiko Hospital, School of Medicine, National and Kapodistrian University of Athens, Agiou Thoma 17 Goudi, 11527, Athens, Greece. Email: geofragoul@yahoo.gr.
Antonis Fanouriakis
Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. G.E. Fragoulis, Joint Academic Rheumatology Program, First Department of Propedeutic Internal Medicine, Laiko Hospital, School of Medicine, National and Kapodistrian University of Athens, Agiou Thoma 17 Goudi, 11527, Athens, Greece. Email: geofragoul@yahoo.gr.
George E. Fragoulis
Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. G.E. Fragoulis, Joint Academic Rheumatology Program, First Department of Propedeutic Internal Medicine, Laiko Hospital, School of Medicine, National and Kapodistrian University of Athens, Agiou Thoma 17 Goudi, 11527, Athens, Greece. Email: geofragoul@yahoo.gr.

Abstract
We read with great interest the article of Meara et al1 in your journal describing a case of chilblain-like lesions after vaccination against SARS-CoV-2. Since the start of the coronavirus disease 2019 (COVID-19) pandemic, millions of vaccine doses have been administered and their safety has been generally confirmed.
In this issue
The Journal of Rheumatology
Vol. 49, Issue 8
1 Aug 2022
Chilblains After SARS-CoV-2 Vaccination: Coincidence or Real Association?
Anastasios Karamanakos, Gerasimos Evangelatos, Maria Pappa, Kalliopi Fragiadaki, Antonis Fanouriakis, George E. Fragoulis
The Journal of Rheumatology Aug 2022, jrheum.220487; DOI: 10.3899/jrheum.220487